![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Bristol-Myers Squibb Reports Results for Phase III Trial of Yervoy in Previously-Treated Castration-Resistant Prostate Cancer
Bristol-Myers Squibb Reports Results for Phase III Trial of Yervoy in Previously-Treated Castration-Resistant Prostate Cancer
September 12, 2013
Bristol-Myers Squibb’s Yervoy did not meet statistical significance criteria in a Phase III trial comparing prostate cancer patients on the drug with those on docetaxel.
The Herald Online
The Herald Online
Upcoming Events
-
21Oct